Cargando…

Real-world analyses of therapy discontinuation of checkpoint inhibitors in metastatic melanoma patients

The ‘real-world’ patient population of metastatic melanoma is not fully represented in clinical trials investigating checkpoint inhibitors. We described therapy discontinuation in an unselected population-based cohort of adults with metastatic melanoma who started therapy with pembrolizumab, nivolum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Machado, Marina Amaral de Ávila, de Moura, Cristiano Soares, Chan, Kelvin, Curtis, Jeffrey R., Hudson, Marie, Abrahamowicz, Michal, Jamal, Rahima, Pilote, Louise, Bernatsky, Sasha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471311/ https://www.ncbi.nlm.nih.gov/pubmed/32884119 http://dx.doi.org/10.1038/s41598-020-71788-z

Ejemplares similares

Relative effectiveness of influenza vaccines in elderly persons in the United States, 2012/2013-2017/2018 seasons
por: Machado, Marina Amaral de Avila, et al.
Publicado: (2021)

Treatment Discontinuation and Clinical Events in Type 2 Diabetes Patients Treated with Dipeptidyl Peptidase-4 Inhibitors or NPH Insulin as Third-Line Therapy
por: Moura, Cristiano S., et al.
Publicado: (2018)

Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study
por: Machado, Marina Amaral de Ávila, et al.
Publicado: (2018)

Sex Differences in Cardiovascular Effectiveness of Newer Glucose‐Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus
por: Raparelli, Valeria, et al.
Publicado: (2020)

Treatment persistence in patients with rheumatoid arthritis and ankylosing spondylitis
por: Machado, Marina Amaral de Ávila, et al.
Publicado: (2016)

Sex Differences in the Effectiveness of Angiotensin‐Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Sacubitril–Valsartan for the Treatment of Heart Failure
por: Sohani, Zahra N., et al.
Publicado: (2023)

Trimethoprim-sulfamethoxazole prophylaxis during treatment of granulomatosis with polyangiitis with rituximab in the United States of America: a retrospective cohort study
por: Mendel, Arielle, et al.
Publicado: (2023)

Predictors of Unsuccessful Hydroxychloroquine Tapering and Discontinuation: Can We Personalize Decision‐Making in Systemic Lupus Erythematosus Treatment?
por: Almeida‐Brasil, Celline C., et al.
Publicado: (2022)

Hospitalization for musculoskeletal disorders in rheumatoid arthritis patients: a population-based study
por: Machado, Marina Amaral de Ávila, et al.
Publicado: (2016)

Antiphospholipid Antibody Testing in a General Population Sample from the USA: An Administrative Database Study
por: Egiziano, Giordano, et al.
Publicado: (2020)

Predictors of long-term use of prescription opioids in the community-dwelling population of adults without a cancer diagnosis: a retrospective cohort study
por: Béliveau, Audrey, et al.
Publicado: (2021)

Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma
por: Ferdinandus, Justin, et al.
Publicado: (2022)

Outcome of Elective Checkpoint Inhibitor Discontinuation in Patients with Metastatic Melanoma Who Achieved a Complete Remission: Real-World Data
por: Perez, Leanne, et al.
Publicado: (2022)

Retreatment of Patients With Metastatic Cutaneous Melanoma Who Relapse After Elective Checkpoint Inhibitor Discontinuation After a Complete Remission
por: Sadrolashrafi, Kaviyon, et al.
Publicado: (2023)

Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
por: Dubin, Krista, et al.
Publicado: (2016)

The Canadian Mother-Child Cohort Active Surveillance Initiative (CAMCCO): Comparisons between Quebec, Manitoba, Saskatchewan, and Alberta
por: Bérard, Anick, et al.
Publicado: (2022)

Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case–control analysis
por: Dixon, William G, et al.
Publicado: (2012)

Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure
por: Essebag, Vidal, et al.
Publicado: (2005)

Validity of hospital diagnostic codes to identify SARS-CoV-2 infections in reference to polymerase chain reaction results: a descriptive study
por: Moura, Cristiano S., et al.
Publicado: (2023)

Population-Level Sex Differences and Predictors for Treatment With Catheter Ablation in Patients With Atrial Fibrillation and Heart Failure
por: Samuel, Michelle, et al.
Publicado: (2020)

Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors
por: Tonneau, Marion, et al.
Publicado: (2022)

Primary malignant melanoma of the vagina: A case report
por: Sticca, Giancarlo, et al.
Publicado: (2023)

Checkpoint Inhibitors Immunotherapy in Metastatic Melanoma: When to Stop Treatment?
por: De Risi, Ivana, et al.
Publicado: (2022)

Effect of menopause on the modified Rodnan skin score in systemic sclerosis
por: Vinet, Évelyne, et al.
Publicado: (2014)

Early medication use in new-onset rheumatoid arthritis may delay joint replacement: results of a large population-based study
por: Moura, Cristiano S., et al.
Publicado: (2015)

Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical Experience
por: Asher, Nethanel, et al.
Publicado: (2021)

Costs of Drug Therapy in Patients with Ankylosing Spondylitis in Brazil
por: Machado, Marina Amaral de Ávila, et al.
Publicado: (2016)

Psoriatic Arthritis with Acral Lentiginous Melanoma: Role for Methotrexate?
por: Rahima, S, et al.
Publicado: (2013)

Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC
por: Sharma, Rohini, et al.
Publicado: (2022)

Phase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma
por: Daud, Adil, et al.
Publicado: (2017)

Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma
por: Anagnostou, Valsamo, et al.
Publicado: (2020)

Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors
por: Mantia, Charlene M., et al.
Publicado: (2021)

Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
por: Schilling, Bastian, et al.
Publicado: (2015)

Cardiovascular Immunotoxicity Associated with Immune Checkpoint Inhibitors in Metastatic Melanoma
por: L’Orphelin, Jean-Matthieu, et al.
Publicado: (2023)

Influenza Vaccine Hesitancy and Its Determinants Among Rheumatology Patients
por: Valerio, Valeria, et al.
Publicado: (2022)

Toxicity, Response and Survival in Older Patients with Metastatic Melanoma Treated with Checkpoint Inhibitors †
por: de Glas, Nienke A., et al.
Publicado: (2021)

Discontinuation of anti‐PD‐1 monotherapy in advanced melanoma—Outcomes of daily clinical practice
por: van Zeijl, Michiel C. T., et al.
Publicado: (2021)

Real-world experience with elective discontinuation of PD-1 inhibitors at 1 year in patients with metastatic melanoma
por: Pokorny, Rebecca, et al.
Publicado: (2021)

An evaluation of methods correcting for cell-type heterogeneity in DNA methylation studies
por: McGregor, Kevin, et al.
Publicado: (2016)

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
por: Heppt, Markus V., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_onaeej6stbraggotji4ralln2d